Tretinoin/benzoyl peroxide
Подписчиков: 0, рейтинг: 0
| Combination of | |
|---|---|
| Tretinoin | Retinoid |
| Benzoyl peroxide | Oxidizing agent |
| Clinical data | |
| Trade names | Twyneo |
| Other names | S6G5T-3 |
| License data | |
| Routes of administration |
Topical |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| KEGG | |
Tretinoin/benzoyl peroxide, sold under the brand name Twyneo, is a fixed-dose combination medication used for the treatment of acne. It contains tretinoin, a vitamin A derivative, and benzoyl peroxide, an oxidizing agent.
The combination was approved for medical use in the United States in July 2021.
External links
- "Tretinoin". Drug Information Portal. U.S. National Library of Medicine.
- "Benzoyl peroxide". Drug Information Portal. U.S. National Library of Medicine.
- Clinical trial number NCT03761784 for "A Study of S6G5T-3 in the Treatment of Acne Vulgaris" at ClinicalTrials.gov
- Clinical trial number NCT03761810 for "A Study of S6G5T 3 in the Treatment of Acne Vulgaris" at ClinicalTrials.gov
| Antibacterial | |
|---|---|
| Keratolytic | |
| Anti-inflammatory | |
| Antibiotics | |
| Hormonal | |
| Retinoids | |
| Other | |
| Combinations | |
| |